EUVIMEDEUVIMED entdecken
Crossref

Assessing Antiaggregant, Anticoagulant, and Blood Product Transfusion Use in Patients Admitted to Intensive Care for Gastrointestinal Bleeding

Kamil Gönderen

Journal of Critical and Intensive Care · 2024

DOI: 10.14744/dcybd.2024.53394 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Critical and Intensive Care, 2024. Verfasst von Kamil Gönderen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Gönderen, K. (2024). Assessing Antiaggregant, Anticoagulant, and Blood Product Transfusion Use in Patients Admitted to Intensive Care for Gastrointestinal Bleeding. Journal of Critical and Intensive Care. https://doi.org/10.14744/dcybd.2024.53394

Vancouver

Gönderen K. Assessing Antiaggregant, Anticoagulant, and Blood Product Transfusion Use in Patients Admitted to Intensive Care for Gastrointestinal Bleeding. Journal of Critical and Intensive Care. 2024. doi:10.14744/dcybd.2024.53394

BibTeX
@article{Gnderen2024,
  author = {Gönderen, Kamil},
  title = {Assessing Antiaggregant, Anticoagulant, and Blood Product Transfusion Use in Patients Admitted to Intensive Care for Gastrointestinal Bleeding},
  journal = {Journal of Critical and Intensive Care},
  year = {2024},
  doi = {10.14744/dcybd.2024.53394}
}
Kostenlos starten →